Business

Nasal Spray Epinephrine Treatment Awaits FDA Approval

The U.S. Food and Drug Administration (FDA) has shocked many by deciding not to approve a pioneering nasal spray as an alternative to current epinephrine autoinjectors, like EpiPens. The announcement was met with surprise, especially from ARS Pharma, the creator of the product named Neffy. The FDA’s move came despite an earlier endorsement in May […]

Read More

McDonald’s Phases Out Self-Serve Soda Machines: Reflecting Changing Consumer Behavior

The iconic fast-food chain, McDonald’s, has announced that it will be discontinuing the use of self-serve beverage stations in its U.S. restaurants by 2032. This change aims to ensure uniformity in the experiences of both customers and workers, regardless of whether the order is placed in person, via the drive-thru, or through the McDonald’s app. […]

Read More

Apple Releases Urgent Security Update to Combat Prolific Spyware Threat

Apple has issued an immediate security update for iPhone and iPad users, urging them to update to iOS 16.6.1 and iPadOS 16.6.1, respectively. The swift release of this update follows the discovery of two critical vulnerabilities, one within the ImageIO framework and the other related to Wallet. This release also encompasses watchOS 9.6.2, aiming to […]

Read More

Kohl’s Q2 Financial Results Amid Broader Retail Challenges

Kohl’s Corp, a prominent department store chain, posted its Q2 results, indicating a decline in both profits and sales. Yet, these figures still managed to surpass Wall Street’s projections. This has come during a time when the retail sector at large grapples with a delicate economic landscape marked by cautious consumer spending, propelled by high […]

Read More

Amazon in Talks to Invest in Arm’s IPO; SoftBank Eyes Major Tech Investors

Amazon.com (AMZN.O) is reportedly engaging in discussions to join other prominent technology companies as a cornerstone investor in SoftBank Group Corp’s Arm Ltd, leading up to its highly anticipated initial public offering (IPO). Insiders unveiled on Tuesday that Amazon’s potential stake in the IPO hasn’t been publicly disclosed until now. This proposed investment brings to […]

Read More

Hyundai and Kia Recall Over 91,000 Vehicles Due to Faulty Oil Pump Causing Fire Risk

Hyundai and Kia are directing owners of specific 2023 and 2024 models to park their vehicles outside and away from structures. The recall is conducted to replace potentially faulty electric oil pumps that may cause an underhood fire. This issue affects more than 91,000 vehicles across both manufacturers’ lineups. The National Highway Traffic Safety Administration […]

Read More

Trust, Honesty, and Putting Others First: Entrepreneur Katherine Grullon Cuervo Shares Her Golden Rules of Running a Thriving Business

Trust is the glue that binds all human relationships. Without trust, you never feel at ease or able to express who you are. Instead, you hold back, fearful of being cheated, hurt, or let down. Whether it’s marriage, team sports, or business, broken trust destroys foundations. The Harvard Business Review recently reported on the effect […]

Read More

Brock Sottile’s Inspiring Journey: Overcoming Loss and Building a Legacy

In the face of adversity, many individuals may crumble under the pressure of their circumstances, allowing their dreams and aspirations to slip away. However, some, like Brock Sottile, triumph over their challenges and carve out a path to success. At the tender age of 23, the CEO of Sottile Capital has already encountered more hurdles […]

Read More

IMF Raises Global Growth Forecast but Cautions on Downside Risks and Inflation

The International Monetary Fund (IMF) recently revised its global growth outlook, exhibiting more optimism than economists had predicted earlier. However, the organization also cautioned about potential difficulties and the persistent risk of inflation. Revised Projections and Underlying Factors The IMF now expects the global economy to grow by 3% in both 2023 and 2024, a […]

Read More

Johnson & Johnson Sues Biden Administration Over New Medicare Drug Pricing Rules

In a significant event, the drug company Johnson & Johnson (J&J) has decided to take legal action against the Biden government due to their contentious Medicare Drug Price Discussion Program, put into place by the Inflation Reduction Act. This indicates that J&J is the third key drug company, coming after Merck & Co. and Bristol […]

Read More